Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis

Of the patients, 43% had a response to botulinum toxin treatment that lasted a mean of approximately 5 months. Male gender was associated with a response to this therapy; however, durability of response was unrelated to gender. Vomiting as a major symptom predicted no response.